Skip to main content
. Author manuscript; available in PMC: 2007 Dec 3.
Published in final edited form as: Toxicol Pathol. 2007;35(4):533–540. doi: 10.1080/01926230701338941

Table 5.

Cell labeling indices determined with PCNA immunostaining during the 13-week prechronic inhalation studies with decalin and propylene glycol mono-t-butyl ether.


Propylene glycol mono-t-butyl ether Chamber Control 75 ppm 150 ppm 300 ppm 600 ppm 1,200 ppm
Labeling index (%) n = 5
Week 2 3.6 ± 0.1 3.6 ± 0.2 3.9 ± 0.2 3.4 ± 0.1 4.4 ± 0.2* 5.5 ± 0.4**
Week 6 3.6 ± 0.1 3.2 ± 0.1 3.4 ± 0.2 3.9 ± 0.1 4.3 ± 0.0* 4.9 ± 0.3*
Week 13 3.2 ± 0.2 3.8 ± 0.2 4.3 ± 0.2** 4.1 ± 0.2* 5.0 ± 0.4** 6.6 ± 0.4**

Decalin Chamber Control 25 ppm 50 ppm 100 ppm 200 ppm 400 ppm

Labeling index (%) n = 5
Week 2 3.3 ± 0.2 4.2 ± 0.1* 3.9 ± 0.3 4.3 ± 0.2** 4.2 ± 0.3* 4.9 ± 0.3**
Week 6 3.2 ± 0.1 4.2 ± 0.1** 4.8 ± 0.1** 4.6 ± 0.3** 5.0 ± 0.2** 5.9 ± 0.3**
Week 13 3.1 ± 0.2 4.5 ± 0.1** 3.7 ± 0.3* 4.1 ± 0.2* 4.5 ± 0.2** 4.5 ± 0.2**
*

Significantly different (p < 0.05) from the chamber control group.

**

p < 0.01, data are presented as mean + S.E.